Terri Jones

Terri Jones is an experienced scientist specializing in Oncology and Immunology, with a robust background in developing and advancing small molecule programs. Current employment at FogPharma as an Associate began in March 2023. Prior to this, Terri served as a Senior Scientist at EMD Serono, Inc. from March 2022 to June 2023, and held roles at Arrakis Therapeutics, Celgene, BiogenIdec, Novartis Institutes for Biomedical Research, The Institute for Diabetes Discovery, and Bayer Pharmaceuticals, accumulating significant expertise in various biochemical assays and high-throughput cell-based screening methods. Terri Jones holds a Master of Science degree in Cell/Cellular and Molecular Biology from the University of New Haven.